Concourse Financial Group Securities’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,724
Closed -$37.7K 2413
2021
Q2
$42K Sell
2,724
-1,436
-35% -$24.1K ﹤0.01% 1373
2021
Q1
$84K Buy
4,160
+488
+13% +$12.1K 0.01% 1012
2020
Q4
$99K Buy
3,672
+421
+13% +$9.44K 0.01% 893
2020
Q3
$60K Buy
3,251
+204
+7% +$3.62K 0.01% 985
2020
Q2
$54K Buy
3,047
+187
+7% +$2.85K 0.01% 958
2020
Q1
$26K Buy
2,860
+13
+0.5% +$194 ﹤0.01% 1140
2019
Q4
$49K Buy
2,847
+1,204
+73% +$16.1K ﹤0.01% 948
2019
Q3
$17K Buy
1,643
+968
+143% +$13K ﹤0.01% 1001
2019
Q2
$11K Buy
675
+521
+338% +$9.3K ﹤0.01% 1449
2019
Q1
$2K Buy
+154
New +$2.73K ﹤0.01% 2011

Other funds holding CLLS

Concourse Financial Group Securities's CLLS Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Cellectis (CLLS) in Q3 2021, closing a stake of 2,724 shares — an estimated $37.7K sold.

Concourse Financial Group Securities first reported a position in CLLS in Q1 2019 and held it in 10 quarters. The position peaked at $99K in Q4 2020. 70 funds tracked by Wall St. Rank hold CLLS as of Q3 2021.

  • Concourse Financial Group Securities reported no remaining Cellectis position as of Q3 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 2,724 Cellectis shares in Q3 2021, an estimated $37.7K.
  • Concourse Financial Group Securities first reported a position in Cellectis in Q1 2019 and held it in 10 quarters.
  • Concourse Financial Group Securities's Cellectis position peaked at $99K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.